Home > Adults > Neurology >

Multiple Sclerosis

Share Print Feedback

Checked: 23-04-2019 by Vicky Ryan Next Review: 23-09-2019

Principles of Management

Refer to the NICE guidance on the recognition and management of MS.

Referral

Patients with suspected MS should be referred to Neurology via eReferral.

Referrals for patients with known MS should be referred to BrAMS (see section below)

Bristol & Avon Multiple Sclerosis Centre (BrAMS)

BrAMS offers a unique service, offering support, information, clinical treatment and therapy and research to people across Bristol and the South West.

The unit offers:

Expert, unrivalled clinical knowledge in multiple sclerosis and associated neurological conditions.
A dedicated specialist MS nurse team offering a range of specialist nurse led clinics, a telephone helpline services and invaluable support to MS patients their families and carers.
A specialist physiotherapist service offering instant access to information, treatment, exercise, balance rehabilitation including vestibular rehabilitation, spasticity reviews, mobility aids, orthotics provision and a monthly joint orthotic clinic.
An intravenous suite allowing access to daycase IV steroids, which are often used to treat patients in times of relapse or those with severe spasticity.

See NBT's BrAMS webpage for further information.

Referrals can be made through e-Referral.

MS Nurse Advice Line
Telephone: 0117 4148288

Community Services

Please see the Specialist Community Neurology page of Remedy for details of community MS services

Neurophysiotherapy

This is a service for outpatients who have any neurological condition, either with or without a formal diagnosis. It is for all adults over 16 and there are no restrictions on location boundaries.

Please see Bristol South Community Hospital website for further details.

Efforts are made to ensure the accuracy and agreement of these guidelines, including any content uploaded, referred to or linked to from the system. However, BNSSG ICB cannot guarantee this. This guidance does not override the individual responsibility of healthcare professionals to make decisions appropriate to the circumstances of the individual patient, in consultation with the patient and/or guardian or carer, in accordance with the mental capacity act, and informed by the summary of product characteristics of any drugs they are considering. Practitioners are required to perform their duties in accordance with the law and their regulators and nothing in this guidance should be interpreted in a way that would be inconsistent with compliance with those duties.

Information provided through Remedy is continually updated so please be aware any printed copies may quickly become out of date.